Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
79,719,412
-
Total 13F shares
-
56,195,243
-
Share change
-
+3,828,698
-
Total reported value
-
$1,402,708,961
-
Put/Call ratio
-
33%
-
Price per share
-
$24.96
-
Number of holders
-
116
-
Value change
-
+$98,529,765
-
Number of buys
-
65
-
Number of sells
-
54
Institutional Holders of Kymera Therapeutics, Inc. - COMMON STOCK (KYMR) as of Q4 2022
As of 31 Dec 2022 Kymera Therapeutics, Inc. - COMMON STOCK (KYMR) had 116 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 56,195,243 shares of stock of the company.
Largest 10 holders included Atlas Venture Life Science Advisors, LLC, BVF INC/IL, WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES INC /MD/, Avoro Capital Advisors LLC, VANGUARD GROUP INC, BlackRock Inc., BAKER BROS. ADVISORS LP, STATE STREET CORP, and Redmile Group, LLC.
This table shows 116 institutional shareholders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.